![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 36, 32421-32429, September 6, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§¶,
§,
,
,
,
,
,
§§, and
¶¶
From the
School of Dentistry, University of
Copenhagen, Nørre Allé 20, 2200 Copenhagen N, Denmark, the
Department of Chemistry, University of New Hampshire, Durham,
New Hampshire 03824, the ** Northwest Biotherapeutics,
Inc., Bothell, Washington 98021, and the

European Molecular Biology Laboratory,
Meyerhofstrasse 1, 69117 Heidelberg, Germany
Received for publication, June 21, 2002, and in revised form, July 18, 2002
| |
ABSTRACT |
|---|
|
|
|---|
The Drosophila genes
fringe and brainiac exhibit sequence
similarities to glycosyltransferases. Drosophila and
mammalian fringe homologs encode
UDP-N-acetylglucosamine:fucose-O-Ser
The neurogenic Drosophila gene brainiac
plays essential roles in epithelial development in the embryo and
in oogenesis (1, 2). brainiac shares sequence similarity
with glycosyltransferases, together with another gene,
fringe (3). Recently it was demonstrated that
fringe encodes a genuine glycosyltransferase (4, 5), raising
the possibility that brainiac may also function as a
glycosyltransferase enzyme. Fringe modulates functions of the Notch
receptor by extending O-linked fucosylation sites in EGF
modules of Notch.
UDP-N-acetylglucosamine:Fuc In Drosophila, brainiac mutants produce defects
that resemble those produced by loss of Notch function
during oogenesis. Consequently, brainiac protein has been considered as
a possible modulator of Notch activity (2). Brainiac activity is
required in the developing germ line for proper organization of the
follicle. Some of the defects associated with loss of brainiac activity
in germ line cells resemble defects associated with loss of Notch
activity. Recently, the role of Notch and its ligand Delta in signaling between germ line and somatic cells has been clarified (7). Delta is
expressed in germ line cells and required for activation of Notch in
somatic follicle cells at two stages of oogenesis. The defects
associated with loss of Notch activity resemble the defects associated
with loss of brainiac in some respects, but differ in other respects.
By analogy to the role of fringe as a modifier of Notch, it is possible
that brainiac acts in the germ line to modify Delta and contribute to
signaling between germ line and somatic cells. However, it is also
possible that brainiac acts differently to influence multiple
interactions between germ line and somatic cells.
In the present study we demonstrate that Drosophila brainiac
is a Phylogenetic Analysis of the Drosophila and Mammalian
Expression of Brainiac in Insect Cells--
An expression
construct of the full coding region of brainiac was prepared
by PCR using D. melanogaster (Canton S) genomic DNA
(CLONTECH) with the sense primer MAB1
(5'-AGCGGATCCGCCATGCAAAGTAAACACCGC-3') and the antisense primer MAB3
(5'-AGCGGATCCTGCTACGCGTAATTGGCGG-3') with BamHI restriction
sites. The PCR product was cloned into the BamHI site of
pVL1393 (PharMingen). Two N-terminal truncated constructs were prepared
to obtain soluble secreted brainiac. One construct,
pAcGP67-brainiac-sol, designed to encode amino acid residues 23-325 of
brainiac was prepared by PCR using the primer pair MAB2
(5'-AGCGGATCCGACTATTGCGGCCTGCTGACC-3') and MAB3 with BamHI
restriction sites. The PCR product was cloned into the BamHI
site of pAcGP67B (PharMingen). A second construct,
pAcGP67-brainiac-HIS-sol, designed to encode a N-terminal fusion of
His6 and T7 tags to amino acid residues 28-325 of
brainiac was prepared by PCR using the primer pair TSHC273
(5'-CGAGGATCCGCTGACCCACCTGCACGAG-3') and MAB3 with BamHI
restriction sites. The PCR product was fused to cDNA for six
histidine residues and a T7 tag interspaced by a thrombin proteolytic
site, and the expression unit was cloned into the NotI
restriction site of pAcGP67A (PharMingen).
pVL1393-brainiac-full, pAcGP67-brainiac-sol, and
pAcGP67-brainiac-HIS-sol were co-transfected with
Baculo-GoldTM DNA (PharMingen) in Sf9 cells as
described (13). Control constructs included pVL-fringe-myc
and pVL-fringe-NNN-myc (4), where NNN represents
an enzymatically inactive DxD motif mutant. Standard assays were
performed in 50-µl total reaction mixtures containing 25 mM HEPES-KOH (pH 7.4), 10 mM MnCl2,
0.1% n-octyl glucoside, 100 µM
UDP-[14C]GlcNAc (2,300 cpm/nmol) (Amersham
Biosciences), and varying concentration of acceptor substrates
(Fluka, Merck, Sigma, and Toronto Research Chemicals Inc.; see Table I
for structures). For microsomal preparations High FiveTM
cells were lysed in 10 volumes of hypotonic lysis buffer (25 mM HEPES-KOH (pH 7.4), 10 mM MnCl2,
1% N-octyl glucoside, 1 mM phenylmethylsufonylfluoride), and membrane pellets obtained by differential centrifugation at 15,000 × g, followed by
150,000 × g were used at 150 mg/ml. The secreted
brainiac constructs were assayed with 5-20 µl of culture supernatant
from infected cells. The His- and T7-tagged secreted brainiac
protein was purified by nickel-nitrilotriacetic acid affinity
chromatography (Qiagen) as described by the manufacturer. In addition
this protein was immunoprecipitated with anti-T7 antibody agarose
(Novagen) as described by the manufacturer, and enzyme assays
were performed on washed beads as well as after elution at low pH.
Reaction products of soluble acceptors were quantified by
chromatography on Dowex 1-X8 (Sigma). Assays with glycosphingolipids
included 5 mM
2-acetamido-2-deoxy-D-glucono-1,5-lactone (inhibitor of
hexosaminidase activity), and products were purified on
octadecyl-silica cartridges (Supelco) and analyzed by high performance
thin-layer chromatography (HPTLC) and autoradiography.
Isolation of CDH and CTH from High FiveTM Insect
Cells--
High FiveTM cells were grown in shaking upright roller
bottles at 27 °C in serum-free medium (Invitrogen). Approximately 50 ml of packed cells were extracted in
2-propanol-n-hexane-water (55/25/20, v/v/v, upper phase
removed) and subjected to Folch partition in chloroform-methanol-water
(4/2/1, v/v/v). The dried lower phase glycolipids were freed from other
lipids by peracetylation (pyridine-acetic anhydride 2:1 v/v),
chromatography on Florisil, and base-catalyzed
O-deacetylation (14) and analyzed by HPTLC. Further
fractionation of wild type High FiveTM glycolipids was carried out by
preparative-scale high performance liquid chromatography. The
structures of the di- and triglycosylceramide fractions were determined
by 1H NMR spectroscopy and electrospray ionization mass
spectrometry to be Man Isolation of the Products Formed by Brainiac--
The products
formed by brainiac with Man- 1H and 13C NMR
Spectroscopy--
Glycosphingolipid products were deuterium exchanged
by repeated addition of CDCl3-CD3OD 2:1,
sonication, and evaporation under nitrogen, then dissolved in 0.5 ml of
Me2SO-d6/2% D2O
(containing 0.03% tetramethylsilane as chemical shift reference) for
NMR analysis. A one-dimensional 1H NMR spectrum was
acquired on the product with LacCer on a 600 MHz Varian Inova
spectrometer at 35 °C, with solvent suppression by presaturation
pulse. Its identity was established by comparison of the spectrum with
those of relevant standards acquired under identical conditions (15).
For the product with MacCer, one-dimensional 1H,
two-dimensional 1H-1H gCOSY, TOCSY, and NOESY
NMR spectra were acquired on a Varian Inova 800 MHz spectrometer at
55 °C. The product with Man MALDI-TOF Mass Spectrometry--
Molecular mass profiles of
glycosphingolipids were acquired on an Axima-CFR (Shimadzu/Kratos
Analytical, Manchester, UK) MALDI-TOF mass spectrometer operating in
positive ion reflectron mode (pulsed N2 laser with delayed
extraction; emission wavelength 337 nm; acceleration potential 5 kV).
The matrix employed was 2,5-dihydroxybenzoic acid; samples were
premixed with a solution of 2,5-dihydroxybenzoic acid (10 mg/ml) in
acetonitrile-0.1% trifluoroacetic acid (1:1, v/v) prior to application
and drying on the target. Molecular species were detected as their
Na+ adducts; angiotensin II and Pro14-Arg were
used as external mass calibration standards (monoisotopic masses 1046.5 and 1533.9 Da, respectively).
Exoglycosidase Digestion--
Brainiac products formed with
lactose, Gal Brainiac Encodes an UDP-GlcNAc:
Several attempts to generate a soluble secreted brainiac protein with
good catalytic activity were performed. Initially, we used an untagged
construct based on amino acid residues 23-325, but no activity was
found in the culture medium of infected insect cells (not shown).
Second, a N-terminally tagged construct based on amino acid residues
28-325 was expressed and a specific protein reactive with an anti-HIS
antibody of predicted molecular weight was found by Western blot
SDS-PAGE analysis. Low activity with Man
Several parameters for the brainiac assay with microsomal fractions
were analyzed for optimization. The most critical parameter was found
to be the detergent solubilization. Triton X-100, Triton CF-54, and
Nonidet P-40 had strong inhibiting effect on activity at 0.1%, while
n-octyl glucoside at 3.4 mM (0.1%) activated
the enzyme. The pH optimum of brainiac activity was neutral (pH 7.4). Addition of 5-10 mM MnCl2 activated enzyme
activity, and MgCl2 and CaCl2 had no effect,
while the presence of EDTA destroyed the activity.
The product of brainiac with Man
Brainiac showed high activity with the disaccharides Gal Brainiac Functions in Glycosphingolipid Synthesis--
On the other hand, the core dihexosylceramide (CDH) of
glycosphingolipids from flies (diptera), including D. melanogaster, and nematodes, including Caenorhabditis
elegans, has been reported to be Man
A one-dimensional 1H NMR spectrum of the crude
triglycosylceramide product formed with LacCer (not shown) exhibited
resonances consistent with virtually complete conversion to
GlcNAc
The triglycosylceramide product formed with MacCer was purified by
preparative HPTLC (see Fig. 5, lane
6), and confirmed by MALDI-TOF mass spectrometry and by
one-dimensional 1H and two-dimensional
1H-1H NMR spectroscopy to be authentic
GlcNAc
Fig. 5 presents an HPTLC comparison of Folch lower phase
glycosphingolipids extracted from High FiveTM cells
infected with a baculovirus expressing an irrelevant gene (lane
1) with those from High FiveTM cells infected with
baculovirus containing pVL1393-brainiac-full (lane
2). In the CTH region of High FiveTM cells infected
with an irrelevant virus (lane 1) the major band corresponds
to Gal The neurogenic gene brainiac was shown to
encode a The acceptor substrate specificity of brainiac with various mono- and
disaccharides and aglycon derivatives revealed clear preference for
Drosophila glycosphingolipids have all been reported so far
to be based on the Ap3Cer core structure and extended as
discussed above. It is noteworthy though that relatively few studies
have addressed Drosophila glycosphingolipids, as well as
insect glycosphingolipids in general, compared with studies of
vertebrate glycosphingolipids. In the biosynthesis of vertebrate
glycosphingolipids built on LacCer, an important branch point occurs at
the addition of the third monosaccharide residue. This is the
determining step for synthesis of different classes of
glycosphingolipids, designated (neo)lactoseries
(GlcNAc The proposed function for brainiac in Drosophila
glycosphingolipid biosynthesis implies that brainiac mutants
may lack extended glycosphingolipids. Drosophila does not
appear to have close brainiac homologs, which would be
predicted to have similar functions (Fig. 8). More distant Drosophila
homologs group independently or with vertebrate orthologs
known to represent
1,3-N-acetylglucosaminyltransferases that modulate the
function of Notch family receptors. The biological function of brainiac
is less well understood. brainiac is a member of a large
homologous mammalian
3-glycosyltransferase family with diverse
functions. Eleven distinct mammalian homologs have been demonstrated to
encode functional enzymes forming
1-3 glycosidic linkages with
different UDP donor sugars and acceptor sugars. The putative
mammalian homologs with highest sequence similarity to
brainiac encode
UDP-N-acetylglucosamine:
1,3-N-acetylglucosaminyltransferases (
3GlcNAc-transferases), and in the present study we show that brainiac also encodes a
3GlcNAc-transferase that uses
-linked mannose as well as
-linked galactose as acceptor sugars.
The inner disaccharide core structures of glycosphingolipids in mammals (Gal
1-4Glc
1-Cer) and insects (Man
1-4Glc
1-Cer) are
different. Both disaccharide glycolipids served as substrates for
brainiac, but glycolipids of insect cells have so far only been found
to be based on the GlcNAc
1-3Man
1-4Glc
1-Cer core structure.
Infection of High FiveTM cells with baculovirus containing
full coding brainiac cDNA markedly increased the ratio
of GlcNAc
1-3Man
1-4Glc
1-Cer glycolipids compared with
Gal
1-4Man
1-4Glc
1-Cer found in wild type cells. We suggest
that brainiac exerts its biological functions by regulating biosynthesis of glycosphingolipids.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1-O-Ser
1,3-N-acetylglucosaminyltransferases (O-Fuc
3GlcNAc-transferase)1
encoded by mammalian fringe orthologs control the
O-linked fucosylation pathway and allow synthesis of the
sialylated tetrasaccharide NeuAc
2-3Gal
1-4GlcNAc
1-3Fuc
1-O-Ser (6). Fringe
may compete with an alternate glycosylation pathway controlled by an
UDP-glucose:Fuc
1-O-Ser
3-glucosyltransferase (6).
3GlcNAc-transferase similar to fringe. However, brainiac has
different acceptor substrate specificity and transfers to
-linked
mannose as well as
-linked galactose residues. The core structure of
Drosophila glycosphingolipids consists of mactosylceramide (Man
1-4Glc
1-Cer; MacCer), and this is extended by a
1-3
linked GlcNAc residue to the terminal mannose residue (8). It is
suggested that brainiac has its primary role in glycosphingolipid
biosynthesis and thereby affects glycosphingolipid mediated receptor
modulation and functions mediated by lipid rafts.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
3-Glycosyltransferase Family--
tBLASTn analysis with
brainiac was used to search the Drosophila
melanogaster whole genome data base GadFly released by the Berkeley Drosophila Genome Project (BDGP, Release 2 and 3) (9). Computed gene sequences were manually revised using EST cDNA
information and the Drosophila Gene collection (DGC Release
1 and 2 (10)). Amino acid sequences representing a central
evolutionarily conserved domain of brainiac and orthologous Homo
sapiens
3-glycosyltransferases were aligned with the identified
D. melanogaster proteins using ClustalX 1.8 with Gonnet 250 protein weight matrix and default gap penalties (11). Multiple sequence
alignments were revised for maximal residue conservation and minimal
gaps in conserved amino acid sequence motifs. Distance analyses of the
amino acid alignments were performed as described (12).
1-4Glc
1-1Cer and
Gal
1-4Man
1-4Glc
1-1Cer,
respectively.2 Total CTH from
control and brainiac transfected High Five cells were isolated from the crude lower phase lipids by preparative HPTLC
and compared by MALDI-TOF mass spectrometry as described below.
-methylumbelliferone (Man
1-MeUmb) (4 mg), High FiveTM MacCer (2 mg), and human Gal
1-4Glc
1-Cer (2 mg)
were analyzed. The substrates were glycosylated with microsomes prepared from High FiveTM cells infected with
pVL-brainiac-full using thin-layer chromatography to monitor
reaction progress. The reaction products were purified by application
to octadecyl-silica cartridges (Bakerbond, J. T. Baker), followed by
stepwise elution with increasing concentrations of methanol in water
(13); the product of reaction with MacCer was further purified by
preparative-scale HPTLC (chloroform-methanol-0.5% aqueous
CaCl2, 50:40:10 v/v/v), with isolation of the fraction migrating as a trihexosylceramide, prior to NMR and mass spectrometry analysis as described below.
1-MeUmb eluting from the
octadecyl-silica cartridge with 20 and 30% MeOH was deuterium
exchanged by repeated lyophilization from D2O and dissolved
in 100% D2O (containing a trace of acetone as chemical shift reference) for NMR analysis. One-dimensional 1H,
two-dimensional 1H-1H gCOSY and TOCSY, and
two-dimensional 1H-detected 1H-13C
gHSQC and gHMBC NMR spectra were acquired on the Varian Inova 600 MHz
spectrometer at 20 °C; a directly detected one-dimensional 13C NMR spectrum was acquired on a Varian Inova 500 MHz spectrometer.
1-4Man, and D-mannose were prepared by
incubating 1 µmol of acceptor sugars with 100 nmol of
UDP-[14C]GlcNAc (3900 cpm/nmol) and brainiac microsomes
in reaction buffer. The reaction products were purified on Dowex 1-X8
and octadecyl-silica cartridges and freeze-dried. The resolubilized
products were digested with 10 units of
-galactosidase
(Escherichia coli, Sigma) for 2 h or 312 milliunits of
-N-acetylglucosaminidase (jack bean, Sigma) overnight and
purified by mixed bed resin chromatography (Sigma) followed by
lyophilization. Resolubilized samples were analyzed by thin-layer
chromatography in chloroform-methanol-water (30:60:10 v/v/v) and autoradiography.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Man/
Gal
1,3GlcNAc-transferase--
Expression of the full coding region of
brainiac resulted in marked increase in GlcNAc-transferase
activity using free D-mannose in a screen assay as
developed for study of the activity of fringe (4). Analysis of
activities with monosaccharides at varying concentrations up to 500 mM with brainiac and fringe is shown in Fig.
1. D-Mannose was the best
substrate for brainiac, but at high concentrations
L-fucose, and to a lesser extent D-galactose, was used as acceptor as well. The activity of brainiac with fucose was
comparable with that of fringe, and fringe also appeared to have weak
activity with mannose. It should be noted that the assays were
quantitated for total microsomal protein, but the relative levels of
enzyme expressions are unknown, and the putative products with
L-fucose were not characterized. The activities were only measurable at acceptor concentrations over 50 mM. In the
case of fringe it did originally indicate that this enzyme functioned with O-linked fucose (4), and later studies suggest that
mammalian fringe variants lunatic and manic exhibit distinct
specificities for the peptide sequence carrying O-Fuc (16).
The high activity at low concentrations brainiac exhibits with other
substrates than fucose clearly indicates that brainiac does not
function in glycosylation of O-linked fucose. Table
I summarizes activities obtained with a
large panel of saccharide and saccharide derivative substrates using
UDP-GlcNAc donor sugar nucleotide. No activity above background values
was obtained with other donor sugar nucleotides (UDP-Glc, UDP-Gal,
UDP-GalNAc, and UDP-xylose) (not shown). Analysis of substrates
containing terminal
-linked mannose (
-Man) and
-linked mannose
showed strong preference for
-Man with monosaccharide derivatives
and near exclusive activity for
-Man structures with disaccharides
and larger. In agreement with free galactose serving as substrate
several disaccharides with terminal
-Gal were used as acceptor.
Gal
1-4Man, lactose, and benzyl-
-lactose were substrates, while
related N-acetylated structures (Gal
1-4ManNAc,
N-acetyllactosamine, benzyl-
-N-acetyllactosamine) were poorly active. Analysis
of apparent Km for the most active substrates
identified showed that Man
1-MeUmb was the preferred acceptor
substrate, and the disaccharides Gal
1-4Man and Gal
1-4Glc were
used with significantly lower affinity (Table
II).

View larger version (16K):
[in a new window]
Fig. 1.
3GlcNAc-transferase activities
of brainiac and fringe with monosaccharides. Microsomes of
transfected High FiveTM cells (3 mg of protein) were used as enzyme
sources.
, brainiac activity with D-mannose;
, fringe
activity with D-mannose;
, brainiac activity with
L-fucose;
, fringe activity with L-fucose;
, brainiac activity with D-galactose;
, fringe
activity with D-galactose. Monosaccharides
D-glucose, D-GalNAc, D-GlcNAc, and
D-xylose are not included, as assays at 5, 50, and 500 mM did not detect enzyme activity. Background values
obtained with identically treated microsomal fractions expressing
pVL-fringe-NNN-myc were subtracted.
Substrate specificities of brainiac
1-3-N-acetylglucosaminyltransferase
Kinetic properties of brainiac
1-3-N-acetylglucosaminyltransferase
1-MeUmb acceptor substrate
was detected in the culture medium (~2-3-fold over background).
Purification of the His-tagged protein by nickel-nitrilotriacetic acid
chromatography resulted in purification of an inactive protein (not
shown). Immunoprecipitation with anti-T7 antibody resulted in specific
precipitation of low activity (~3-4-fold over background), but
elution inactivated the protein. We did not further pursue the
enzymatic properties of the soluble brainiac protein. In our experience
several of the glycosyltransferases acting exclusively in the
glycolipid biosynthetic pathways are enzymatically inactive as
truncated soluble recombinant proteins expressed in insect cells (17,
18).
1-MeUmb was determined by NMR
analysis to be GlcNAc
1-3Man
1-MeUmb, as follows. As shown in Fig.
2A, the fraction of product
eluted from octadecyl-silica by 20% MeOH exhibited sets of
1H resonances indicating a mixture of two compounds (two
sets of
-Man H-1 and H-2 signals in proportion ~6:4, at
5.408/4.339 and 5.436/4.242 ppm, respectively). One set clearly
corresponds to unreacted starting material and the other to a product
of glycosylation by
-GlcNAc (additional H-1 signal at 4.757 ppm,
3J1,2 = 8.5 Hz, NAc signal at 2.085 ppm). Following complete assignment of 1H and
13C resonances from all three monosaccharide spin systems
present (see Table III) by
two-dimensional 1H-1H gCOSY and TOCSY,
one-dimensional 13C, and two-dimensional
1H-detected 1H-13C gHSQC
experiments (not shown), the connectivity between the
-GlcNAc and
the more abundant
-Man spin system was established unambiguously as
a 1
3 linkage by a two-dimensional gHMBC experiment. This spectrum
(Fig. 2B) shows clear interglycosidic three-bond correlations between the
-GlcNAc H-1 and the downfield-shifted
-Man C-3 (79.61 versus 72.44 ppm), as well as between the
corresponding
-HexNAc C-1 (98.81 ppm) and the downfield-shifted
-Man H-3 (3.986 versus 3.804 ppm). Slight upfield shifts
of the corresponding
-Man C-2 and C-4 resonances in the product
compared with the non-glycosylated starting material (Table III) are
also consistent with the
1
3 linkage.

View larger version (21K):
[in a new window]
Fig. 2.
600-MHz NMR spectra (100% D2O,
20 °C) of product of brainiac with
Man-
-methylumbelliferone. A,
expansion of monosaccharide ring methine and hydroxymethyl
proton region of one-dimensional 1H NMR spectrum;
B, corresponding region of two-dimensional
1H-detected 1H-13C gHMBC spectrum.
Interglycosidic three-bond correlations are marked by ovals in
B. MU, 4-methylumbelliferone; S,
resonances corresponding to starting material; P, resonances
corresponding to product.
1H, 13C chemical shifts (ppm) and 3J1,2
coupling constants (Hz, in parentheses) for Man
1-MeUmb substrate and
biosynthetic GlcNAc
1-3Man
1-MeUmb product
1-4Man and
Gal
1-4Glc. D-Galactose and Gal
-MU were poor
substrates with no activity detected at 20 mM.
D-Galactose in excess of 100 mM did, however,
show significant activity. Since the enzyme transfers GlcNAc to both
D-galactose and D-mannose monosaccharides, it
was necessary to determine which sugar served as the acceptor in the disaccharide substrate Gal
1-4Man. This was done by analysis
of sensitivity to exoglycosidase treatment. The di- and trisaccharide products with lactose, Gal
1-4Man, and D-mannose were
digested by
-N-acetylglucosaminidase and not by
-galactosidase treatment suggesting that the structures of the
brainiac products are GlcNAc
1-3Gal
1-4Glc, GlcNAc
1-3Gal
1-4Man, and GlcNAc
1-3Man, respectively (Fig.
3).

View larger version (58K):
[in a new window]
Fig. 3.
Exoglycosidase digestion of brainiac products
formed with Gal
1-4Man,
Gal
1-4Glc and D-Mannose.
Autoradiography of high perfomance thin-layer chromatography of
brainiac products digested with jack bean
-N-acetylglucosaminidase (lanes 1-6) and
E. coli
-galactosidase (lanes
7-12). Chromatography of purified saccharides was performed in
chloroform-methanol-water (30/60/10, v/v/v). The migration of standard
mono- and disaccharides is indicated. Complete digestion of
disaccharide substrates by
-galactosidase was
observed by orcinol staining (not shown).
-GlcNAcase,
-N-acetylglucosaminidase.
-Linked
mannose is rare in eukaryotic glycoconjugates. The preformed
dolichol-phosphate oligosaccharide precursor for
N-glycosylation contains a Man
1-4GlcNAc
linkage, but this only serves as a substrate for
-mannosyltransferases. Brainiac was not active with hen egg albumin
tested as described previously (19), indicating that high mannose and
hybrid-type N-glycans do not serve as substrates (data not shown).
1-4Glc
1-1Cer (MacCer),
and this is extended by
1-3-linked GlcNAc in all structures
characterized to date from these species (8, 20-22). We therefore
isolated MacCer as well as a major glycolipid migrating as a
trihexosylceramide (CTH) from High FiveTM insect cells. The
latter was found to have the novel structure, Gal
1-4Man
1-4Glc
1-1Cer, instead of the GlcNAc
1-3
terminated structure. As shown in Fig. 4
brainiac uses both LacCer (lane 6) and MacCer (lane
7). The enzyme source used was a detergent-solubilized microsomal
fraction, and some endogenous products were produced (lane
5). These endogenous products appear to be genuine products of
brainiac as control experiments with fringe microsomes did not produce
these (lane 1). Two endogenous products migrating in the CTH
region and one migrating in the ceramide tetrasaccharide region were
observed. The identities of these remain unknown. Similarly, the
endogenous product migrating in the ceramide tetrasaccharide region is
likely to be GlcNAc
1-3Gal
1-4Man
1-4Glc
1-1Cer based on
the existence of Gal
1-4Man
1-4Glc
1-1Cer in High
FiveTM cells. The fastest migrating endogenous product
almost co-migrated with the product formed with LacCer. This may
suggest that LacCer is found in High FiveTM cells in
addition to the more predominant MacCer. Co-existence of MacCer and
minor amounts of LacCer was previously reported in Calliphora
vicina (23). The product formed with LacCer migrated slightly
faster than the product formed with MacCer.

View larger version (69K):
[in a new window]
Fig. 4.
Brainiac uses MacCer and LacCer
glycosphingolipid substrates. Assays were performed with
microsomal fractions of High FiveTM cells expressing full
coding constructs of fringe (lanes 1-4) and brainiac
(lanes 5-8). Autoradiography of high performance thin-layer
chromatography of reaction products (4 h) purified by Sep-Pak C-18
chromatography. Plate was run in chloroform-methanol-water (60/38/10,
v/v/v). Migration of standard glycolipids is indicated. H5CTH, High
FiveTM ceramide trihexoside.
1-3Gal
1-4Glc
1-1Cer, i.e. anomeric signals
at 4.620, 4.264, and 4.168 ppm
(3J1,2 = 8.0, 7.3, and 7.8 Hz,
respectively), corresponding to H-1 of GlcNAc
1-3, Gal
1-4, and
Glc
1-1 residues, as well as signals at 3.837 ppm, corresponding to
H-4 of Gal
1-4 (3J3,4 = 2.6 Hz),
and at 1.836 ppm (singlet, 3H), corresponding to NAc of
GlcNAc
1-3, of this glycosphingolipid (compared with published
values for these resonances in an NMR study of an authentic standard:
4.621, 4.265, 4.168 ppm (3J1,2 = 7.9, 7.3, and 7.9 Hz, respectively); 3.839 ppm
(3J3,4 = 2.4 Hz); 1.837 ppm
(singlet, 3H] (15)).
1-3Man
1-4Glc
1-1Cer (Ap3Cer). The major
ions in the mass profile (Fig.
6A) are consistent with
Na+ adducts of a glycosphingolipid product having the
glycan formula HexNAc·Hex2 attached to ceramides composed
of d14:1 and d16:1 sphing-4-enines N-acylated with 18:0,
20:0, 22:0, and 24:0 fatty acids (predominantly d14:1/20:0 and
d14:1/22:0, m/z 1087.5 and 1115.6, respectively), a profile
reflecting the origin of the acceptor substrate, MacCer isolated from
High FiveTM cells.2 NMR spectroscopic
assignments for all 1H resonances in starting material and
product, derived from high resolution gCOSY and TOCSY experiments, are
compiled in Table IV. As shown in Fig.
7, the one-dimensional 1H NMR
spectrum of the product (A), compared with that of the
starting material (B), exhibits an additional
anomeric resonance, connected to a
-GlcNAc spin system (H-1 at 4.539 ppm, 3J1,2
8 Hz, overlapping the
-Man H-1 at 4.534 ppm). Although the near coincidence of the two H-1
signals in the product spectrum made it difficult to establish the
linkage between the
-GlcNAc and
-Man by two-dimensional NOESY
experiments (relevant correlation peaks were insufficiently resolved,
even at 800 MHz; not shown), a comparison of the chemical shifts of all
1H resonances for
-Man in the starting material and
product shows that the largest downfield glycosylation-induced shift
change occurs for H-3 (3.470 versus 3.270 ppm; 
= 0.20 ppm). Such a large downfield shift change is generally a reliable
indication of the position of glycosylation, in the absence of unusual
conformational effects or interactions between vicinally substituted
residues, and in light of the linkage specificity already established
for the Man
1-MeUmb product, the identity of the product with MacCer appears to be confirmed.

View larger version (43K):
[in a new window]
Fig. 5.
HPTLC analysis of glycosphingolipids from
High FiveTM cells infected with baculovirus expressing full
coding brainiac. Compared are total Folch lower phase
glycosphingolipids from High FiveTM cells infected with
baculovirus expressing an irrelevant protein (lane 1), High
FiveTM cells infected with baculovirus expressing full
coding brainiac (lane 2), authentic
Gal
1-4Man
1-4Glc
1-1Cer (Hi5-3) isolated and previously
characterized from High FiveTM cells (lane 3),
total CTH fraction from High FiveTM cells infected with
baculovirus expressing an irrelevant protein (lane 4), total
CTH fraction from High FiveTM cells with baculovirus
expressing full coding brainiac (lane 5),
Ap3Cer produced by in vitro enzymatic
glycosylation of High FiveTM Man
1-4Glc
1-1Cer
(MacCer) with brainiac (lane 6). Solvent system was
chloroform-methanol-0.5% aqueous CaCl2 (50:40:10 v/v/v),
and plates were developed with orcinol H2SO4
staining.

View larger version (29K):
[in a new window]
Fig. 6.
MALDI-TOF mass spectrometry of purified
triglycosylceramide fractions from High FiveTM cells
infected with baculovirus expressing full coding
brainiac. Compared are sodiated molecular ion profiles
of GlcNAc
1-3Man
1-4Glc
1-1Cer produced by in vitro
enzymatic glycosylation of: Man
1-4Glc
1-1Cer with brainiac
(A), total CTH fraction from control-transfected High
FiveTM cells (B), total CTH fraction from
brainiac-transfected High FiveTM cells
(C). Only monoisotopic peaks are labeled. Fractions analyzed
by MALDI-TOF are the same as those analyzed by HPTLC shown in Fig. 5
(corresponding to lanes 6, 4, and 5,
respectively).
1H chemical shifts (ppm) and 3J1,2 coupling
constants (Hz, in parentheses) for Man
1-4Glc
1-1Cer substrate
and biosynthetic GlcNAc
1-3Man
1-4Glc
1-1Cer product

View larger version (24K):
[in a new window]
Fig. 7.
Downfield region of 800-MHz 1H
NMR spectrum (Me2SO-d6/2%
D2O, 55 °C) of
GlcNAc
1-3Man
1-4Glc
1-1Cer
produced by in vitro enzymatic glycosylation of
Man
1-4Glc
1-1Cer
with brainiac (A). A spectrum of the starting
material acquired under identical conditions is reproduced in
B. Arabic numerals refer to ring protons of
residues designated by Roman numerals or capital
letters in the corresponding structure. R refers to
protons of the sphingosine backbone; cis refers to vinyl
protons of unsaturated fatty-N-acyl components.
Asterisks denote resonances from other lipid impurities;
two asterisks appear where large interfering peaks have been
truncated for clarity.
1-4Man
1-4Glc
1-1Cer (Hi5-3). A small amount of
Ap3Cer, which migrates with a relative mobility slightly
higher than Hi5-3 (compare migration of authentic standards analyzed under identical conditions, lanes 6 and 3,
respectively), can also be observed in the wild type profile. This is
consistent with results obtained previously.2 In the CTH
region of the pVL1393-brainiac-full profile (lane 2), the
amount of the higher Rf band is considerably greater, with
intensity of staining almost equal to that of the Hi5-3 band. The
identity of this higher Rf component was confirmed as
follows. Total CTH fractions from control and brainiac
infected High FiveTM cells lower phase glycosphingolipids
were isolated by preparative HPTLC; these fractions (Fig. 5,
lanes 4 and 5, respectively) were then analyzed
by MALDI-TOF mass spectrometry under identical conditions (Fig. 6,
B and C, respectively). The major ions in the
control transfected CTH spectrum (B) are consistent with
Na+ adducts of a glycosphingolipid with the glycan formula
Hex3Cer, having a ceramide profile qualitatively
and quantitatively similar to that already described above for the
biosynthetic Ap3Cer (again predominantly d14:1/20:0 and
d14:1/22:0, m/z 1046.4 and 1074.5, respectively). The
presence of a small amount of Ap3Cer in the wild type
profile is indicated by a set of less abundant Na+ adduct
ions at m/z +41 increments (compare profile in
A). In the CTH spectrum from brainiac-transfected cells
(C) the sets of Na+ adduct ions corresponding to
HexNAc·Hex2Cer and Hex3Cer are almost equal
in abundance, consistent with a substantial increase in the amount of
Ap3Cer relative to that of
Gal
1-4Man
1-4Glc
1-1Cer, as observed by HPTLC analysis.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
3GlcNAc-transferase with broad acceptor substrate
specificity having preference for
-Man but also showing significant
activity with
-Gal terminating structures. Mannose-linked
1-4 is
found in the core structure of insect and nematode arthroseries
glycolipids as mactosylceramide (8), and brainiac was shown to have
activity with this glycolipid. Brainiac also showed activity with
another disaccharide glycolipid, lactosylceramide, which represents the
equivalent core structure upon which vertebrate glycosphingolipids are
built. With the present knowledge of structures of
Drosophila glycoconjugates mactosylceramide is the
only likely natural substrate identified, indicating that brainiac
serves an important function in the biosynthesis of glycosphingolipids.
-linked mannose (Table I). Furthermore, brainiac showed preference
for dihexosides (Gal
1-4Glc and Gal
1-4Man), whereas
disaccharides with penultimate N-acetylglucosamine
represented poor substrates (Gal
1-4GlcNAc and Man
1-4GlcNAc). In
agreement with this brainiac used MacCer and LacCer
glycolipid substrates in in vitro tests. Extended
glycosphingolipids of Drosophila and other dipterans have
been reported to contain two
1-3 linked GlcNAc residues
(e.g.
Gal
1-3GalNAc
1-4GlcNAc
1-3Gal
1-3GalNAc
1-4GalNAc
1-4GlcNAc
1-3Man
1-4Glc
1-Cer) (20, 24). Since brainiac showed poor activity with disaccharide structures containing internal n-acetylhexosamine and no
activity with the disaccharide Gal
1-3GalNAc
1-benzyl, it appears
unlikely that brainiac also catalyzes the addition of the outer GlcNAc residue (Table I).
1-3Gal
1-4Glc
1-Cer), (iso)globoseries Gal
1-3/4Gal
1-4Glc
1-Cer), and ganglioseries
(GalNAc
1-4Gal
1-4Glc
1-Cer) (25). These classes of glycolipids
are differentially expressed in cell types and during cell
differentiation (26-28) and have different properties and functions
(25). There may be no analogous branch point in the biosynthesis of
Drosophila glycosphingolipids, as only one CTH sequence,
GlcNAc
1-3MacCer (Ap3Cer), has been reported from this
species. On the other hand, it is possible that additional structures
and pathways exist. Although Gal
1-4Man
1-4Glc
1-Cer was found
as the major CTH component in High FiveTM cells, and this
structure may represent an aberrant pathway confined to cultured insect
cells, its appearance implies that a Gal
1-4 transferase with
substrate specificity for MacCer must be present in the insect
repertoire. It is also possible that the alternative pathway relates to
the lepidopteran, rather than dipteran, origin of the cell line. We
were not successful in establishing a stable brainiac
transfectant of High FiveTM cells, but analysis of the
glycosphingolipid profile of baculovirus infected cells showed that
brainiac functioned and produced a significant shift in trihexoside
ceramides to Ap3Cer. Brainiac is homologous to vertebrate
3GlcNAc-transferase enzymes that control the (neo)lactoseries
pathway in vertebrates by forming GlcNAc
1-3Gal
1-4Glc
1-Cer
(3, 18, 29-32), and brainiac was found to use LacCer similarly to the
homologous mammalian
3GlcNAc-transferases (Fig. 4). This provides
strong support for the proposed role for brainiac in glycosphingolipid
biosynthesis from a functional perspective.
3-galactosyltransferases. It is therefore
possible that this class of glycosphingolipids cannot be produced in
brainiac mutant animals. Brainiac is required in the germ
line during oogenesis and is also expressed zygotically. At present it
is not technically feasible to isolate sufficient numbers of maternally
and zygotically mutant animals to permit analysis of the
glycosphingolipid composition. Failure to extend glycosphingolipids
beyond MacCer could also lead to lack of acidic and
zwitterionic glycosphingolipids in Drosophila, which contain glucuronic acid linked to galactose residues and phosphoethanolamine linked to GlcNAc residues (8, 24). Charged residues, glucuronic acid
and sialic acids, of glycoconjugates are important for biological functions in vertebrates (33), and it is likely that glucuronic acid
and phosphoethanolamine exert important functions in
Drosophila as well.

View larger version (16K):
[in a new window]
Fig. 8.
Phylogram of
3-glycosyltransferases in D. melanogaster and H. sapiens. The
consensus tree from protein distance analyses of predicted catalytic
3-glycosyltransferase domains is based on progressive sequence
alignments as described under "Experimental Procedures." Bootstrap
percentage values from 1000 replicates are indicated above the nodes.
Putative D. melanogaster
3-glycosyltransferases are
indicated by their GadFly annotation.
3GalT,
3GnT, and
3GalNAcT indicate human
3-galactosyltransferases,
3-N-acetylglucosaminyltransferases, and
3-N-acetylgalactosaminyltransferases, respectively.
Phylogenetic subfamilies are indicated by alternate background
shading. Sequence alignments included amino acids 78-315 of
human
3GalT1 (GenBankTM accession number E07739),
151-394 of
3GalT2 (GenBankTM accession number Y15060),
78-320 of
3GalNAcT1 (
3GalT3, GenBankTM accession
number Y15062), 71-343 of
3GalT4 (GenBankTM
accession number Y15061), 56-296 of
3GalT5
(GenBankTM accession number AB020337), 57-313 of
3GalT6
(GenBankTM accession number AY050570), 142-387 of
3GnT2 (GenBankTM accession number AB049584), 107-355 of
3GnT3 (GenBankTM accession number AB049585), 118-360
of
3GnT4 (GenBankTM accession number AB049586), 88-333
of
3GnT5 (GenBankTM accession number AB045278), and
117-367 of
3GnT6 (GenBankTM accession number AB073740).
The analysis included amino acids 78-316 of D. melanogaster
brainiac (GenBankTM accession number U41449), 85-342 of
CG3038 (DGC accession number AY061226), 109-359 of CG8976 (DGC
accession number AY071036), 99-366 of the predicted CG8734 protein
sequence, 329-563 of the predicted CG8668 protein, and 134-387 of the
predicted CG11357 protein. The predicted CG8673 cDNA sequence was
manually revised as described (12) and found to encode a protein of 364 amino acids; amino acids 109-350 were included in the analysis.
The large vertebrate
3-glycosyltransferase family homologous to
brainiac (29) (Fig. 8) has been extensively characterized within the
last few years. Functional subgroups with considerable apparent
redundancies have been identified, and many of these have been assigned
important roles in the biosynthesis of all glycosphingolipid classes in
mammals. One group is represented by UDP-Gal:
GlcNAc
3-galactosyltransferases,
3Gal-T1, -T2, and -T5, which are
predicted to control synthesis of type 1 chain lactoseries structures
on glycolipids and N- and O-linked glycoproteins (18, 34, 35). All three function in vitro with glycolipids, whereas only
3Gal-T2 has activity with
N-linked glycoproteins, and only
3Gal-T5
functions with O-linked core 3 structures (29). Note that murine
3Gal-T3 was originally erroneously proposed to
function in lactoseries synthesis (36); however,
3Gal-T3, renamed as
3GalNAc-T1, is unique and functions in globoseries glycolipid
biosynthesis forming GalNAc
1-3Gal
1-4Gal
1-4Glc
1-Cer (37).
Surprisingly, a recent report indicated that this gene was essential in
mice (38). However, the orthologous gene in man is inactivated in
healthy individuals of the rare Pk blood group (39).
3Gal-T4 is also unique and functions in ganglioseries glycolipid
biosynthesis forming Gal
1-3GalNAc
1-4Gal
1-4Glc
1-Cer (18,
40). Again,
3Gal-T6 was originally erroneously reported as
3GnT
with a
3GlcNAc-transferase activity similar to brainiac (41);
however, a recent report shows that this gene encodes the
Gal-I enzyme involved in the proteoglycan core region synthesis (Gal
1-3Gal
1-4Xyl
1-O-Ser) (42). A single
Drosophila ortholog (CG8734) is predicted to have similar
enzymatic functions. The human core 1
3Gal-T
(Gal
1-3GalNAc
1-O-Ser/Thr) is only distantly related and groups
in an independent clade with two Drosophila orthologs (not
shown) (43).
The dendrogram in Fig. 8 based on protein distance analyses of the
putative catalytic units of the
3-glycosyltransferase family depicts
brainiac in a subfamily with five mammalian orthologs, which are all
known to function as
3GlcNAc-transferases.
3GnT2 functions in
poly-N-acetyllactosamine synthesis
(GlcNAc
1-3Gal
1-4Glc[NAc]) of glycoproteins and glycolipids
(30, 44).
3GnT3 was shown to function as a core 1 extension enzyme
(GlcNAc
1-3Gal
1-3GalNAc
1-O-Ser/Thr) (45). The
function of
3GnT4 may be related to the function of
3GnT2,
although only low activity has been demonstrated thus far (30).
3GnT5 also has similar functions, and it may have a primary function
in glycosphingolipid biosynthesis
(GlcNAc
1-3Gal
1-4Glc
1-Cer) (31). Finally, the most
distant of the close
3GlcNAc-T brainiac orthologs,
3GnT6, was
recently shown to represent a core 3 enzyme (GlcNAc
1-3GalNAc
1-O-Ser/Thr) (32). The mammalian
3GnTs thus all use
Gal or
GalNAc as acceptor sugar, while brainiac uses both
terminal
Gal and
Man. Human
3GnT2 in contrast to brainiac does not function with
MacCer.3
The phenotypes associated with brainiac mutations have led
to the proposal that it might modulate the activities of several signaling pathways, including Delta/Notch and TGF
/EGF
(1, 2, 46). Could the diversity of effects observed in these mutants be
due to an influence of glycosphingolipids on signaling? In
vertebrates, glycosphingolipids are known to modulate receptor function
and signaling pathways through direct interaction with receptors (47,
48) and through formation of lipid rafts which provide structurally
distinct membrane domains for localization of receptors and ligands
(47, 49). Drosophila lipid rafts have been identified and
shown to be enriched with MacCer (50). It is therefore proposed that
brainiac exerts its biological functions in Drosophila by
directing glycosphingolipid biosynthesis, rather than by
directly modifying receptor molecules as established for fringe. brainiac mutants may therefore provide a unique
genetically tractable system to study the biological role of
glycosphingolipids in vivo.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Heidi Geiser (Department of Chemistry, University of New Hampshire) for her expert help in acquisition of MALDI-TOF mass spectra; the University of Georgia Complex Carbohydrate Research Center for use of their Varian 500, 600, and 800 MHz NMR spectrometers; and Dr. John Glushka for providing invaluable assistance with NMR data acquisition.
| |
FOOTNOTES |
|---|
* This work was supported by The Danish Cancer Society, the Velux Foundation, the Danish Medical Research Council, the Lundbeck Foundation, the National Institutes of Health Resource Center for Biomedical Complex Carbohydrates (NIH P41 RR05351), and Biological Research Infrastructure Network-Center for Structural Biology (NIH P20 RR16459).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ These authors contributed equally and should be considered joint first authors.
¶ Present address: Inst. of Biochemistry II, University of Cologne, Joseph-Stelzmann-Str. 52, 50931 Köln, Germany.
§§ Present address: Dept. of Molecular Biology, MEM-L71, The Scripps Research Inst., 10550 North Torrey Pines Rd., La Jolla, CA 92037.
¶¶ To whom correspondence should be addressed: School of Dentistry, Nørre Alle 20, DK-2200 Copenhagen N, Denmark. Tel.: 45-35326835; Fax: 45-35326505; E-mail: henrik.clausen@odont.ku.dk.
Published, JBC Papers in Press, July 18, 2002, DOI 10.1074/jbc.M206213200
2 M. Fuller, T. Schwientek, H. Clausen, and S. B. Levery, manuscript in preparation.
3 T. Schwientek, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
3GlcNAc-transferase, UDP-N-acetylglucosamine:acceptor
1,3-N-acetylglucosaminyltransferase;
Cer, ceramide;
CDH, ceramide dihexoside;
CTH, ceramide trihexoside;
LacCer, lactosylceramide;
MacCer, mactosylceramide;
TOCSY, total
correlation spectroscopy;
gCOSY, gradient-enhanced correlation
spectroscopy;
NOESY, nuclear overhauser effect spectroscopy;
gHSQC, gradient-enhanced heteronuclear single quantum correlation;
gHMBC, gradient-enhanced heteronuclear multiple bond correlation;
MeUmb, 4-methylumbelliferone;
3Gal-T, UDP-galactose: acceptor
1,3-galactosyltransferase;
HPTLC, high performance
thin-layer chromatography;
MALDI-TOF, matrix-assisted laser
desorption ionization time-of-flight;
Ap3Cer, GlcNAc
1-3Man
1- 4Glc
1-1Cer.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Goode, S., Wright, D., and Mahowald, A. P. (1992) Development (Camb.) 116, 177-192[Abstract] |
| 2. | Goode, S., Morgan, M., Liang, Y. P., and Mahowald, A. P. (1996) Dev. Biol. 178, 35-50[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Yuan, Y. P., Schultz, J., Mlodzik, M., and Bork, P. (1997) Cell 88, 9-11[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Brückner, K., Perez, L., Clausen, H., and Cohen, S. (2000) Nature 406, 411-415[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Moloney, D. J., Panin, V. M., Johnston, S. H., Chen, J., Shao, L., Wilson, R., Wang, Y., Stanley, P., Irvine, K. D., Haltiwanger, R. S., and Vogt, T. F. (2000) Nature 406, 369-375[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Moloney, D. J.,
Shair, L. H., Lu, F. M.,
Xia, J.,
Locke, R.,
Matta, K. L.,
and Haltiwanger, R. S.
(2000)
J. Biol. Chem.
275,
9604-9611 |
| 7. | Lopez-Schier, H., and St Johnston, D. (2001) Genes Dev. 15, 1393-1405 |